BioMarin Pharmaceutical Inc. (BMRN)

NASDAQ: BMRN · Real-Time Price · USD

61.46

+1.55 (2.59%)

At close: Aug 6, 2026, 4:00 PM EDT

64.55

+3.09 (5.03%)

After-hours: Aug 6, 2026, 7:45 PM EDT

BioMarin Pharmaceutical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,407	3,221	2,854	2,419	2,096	1,846
Revenue Growth	11.20%	12.87%	17.97%	15.42%	13.53%	-0.76%
Cost of Revenue	813.59	717.44	580.24	532.06	503.02	470.52
Gross Profit	2,593	2,504	2,274	1,887	1,593	1,376
Selling, General & Admin	1,368	1,153	1,009	892.41	823.24	759.38
Depreciation & Amortization Expenses	87.67	19.39	43.26	62.21	67.19	69.93
Research & Development	987.64	921.93	747.18	746.77	649.61	628.79
Other Operating Expenses	-	-	-10	-	-108	-
Total Operating Expenses	2,444	2,094	1,789	1,701	1,432	1,458
Operating Income	149.26	409.48	484.21	185.77	160.97	-82.34
Interest Income	70.1	74.9	74.88	58.34	18.03	10.48
Interest Expense	-83.61	-10.9	-12.67	-17.34	-15.97	-15.34
Other Non-Operating Income (Expense)	13.36	9	-4.67	-38.22	-13.46	11.85
Total Non-Operating Income (Expense)	-0.15	73	57.55	2.79	-11.4	6.99
Pretax Income	149.11	482.48	541.76	188.56	149.58	-75.35
Provision for Income Taxes	76.14	133.58	114.9	20.92	8.02	-11.27
Net Income	72.97	348.9	426.86	167.65	141.56	-64.08
Net Income to Common	72.97	348.9	426.86	167.65	141.56	-64.08
Net Income Growth	-88.90%	-18.26%	154.62%	18.43%	-	-
Shares Outstanding (Basic)	193	192	190	188	185	183
Shares Outstanding (Diluted)	194	197	197	192	189	183
Shares Change	-1.38%	0.35%	2.67%	1.39%	3.34%	-4.61%
EPS (Basic)	0.38	1.82	2.25	0.89	0.76	-0.35
EPS (Diluted)	0.37	1.80	2.21	0.87	0.75	-0.35
EPS Growth	-89.02%	-18.55%	154.02%	16.00%	-	-
Free Cash Flow	738.18	724.96	487.42	62.57	54.94	208.96
Free Cash Flow Growth	6.23%	48.73%	679.02%	13.88%	-73.71%	-
Free Cash Flow Per Share	3.80	3.67	2.48	0.33	0.29	1.14
Gross Margin	76.12%	77.73%	79.67%	78.01%	76.00%	74.52%
Operating Margin	4.38%	12.71%	16.97%	7.68%	7.68%	-4.46%
Profit Margin	2.14%	10.83%	14.96%	6.93%	6.75%	-3.47%
FCF Margin	21.67%	22.51%	17.08%	2.59%	2.62%	11.32%
EBITDA	302.23	489.04	580.64	290.16	262.94	25.7
EBITDA Margin	8.87%	15.18%	20.35%	11.99%	12.54%	1.39%
EBIT	149.26	409.48	484.21	185.77	160.97	-82.34
EBIT Margin	4.38%	12.71%	16.97%	7.68%	7.68%	-4.46%
Effective Tax Rate	51.06%	27.69%	21.21%	11.09%	5.36%	14.96%

SEC Filings: 10-K · 10-Q